Navigation Links
Pressurized virus blasts its infectious DNA into human cells
Date:7/24/2013

The virus that causes those painful lip blisters known as cold sores has an internal pressure eight times higher than a car tire, and uses it to literally blast its infectious DNA into human cells, scientists are reporting in a new study. Discovery of the pressure-driven infection mechanism the first in a human virus opens the door to new treatments for viral infections, they add in a study in the Journal of the American Chemical Society.

Alex Evilevitch and colleagues point out that the viruses responsible for influenza, AIDS and other infections that affect millions of people annually are quick to develop resistance to drugs that target viral proteins. Through genetic mutations, these proteins can quickly disguise themselves and evade anti-viral drugs. That has led to a search for vulnerabilities that don't involve viral proteins. Evilevitch's team looked at the pressure inside the herpes simplex virus 1 (HSV-1), the virus that causes cold sores.

They describe how HSV-1 enters cells, docks with portals on the nucleus and injects DNA with high pressure caused by tight packing of the capsid, the tough shell that houses the viral genome. Researchers already knew that several viruses that infect bacteria, called bacteriophages, use the same high-pressure mechanism to shoot their DNA into bacteria nuclei. Evilevitch and colleagues conclude that evolution has preserved this effective technique as a key step in viral infection making it a desirable target for future treatments to defeat HSV-1 and other viruses that work the same way. The same mechanism exists in eight related viruses, including those responsible for mononucleosis and chickenpox in children, and shingles in adults. Drugs that interfere with it thus could limit "the potential for development of drug resistance that can occur due to rapid adaptive mutations of viral genomes," the scientists state.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Studies reveal structure of EV71, a virus causing childhood illnesses
2. Discovery provides blueprint for new drugs that can inhibit hepatitis C virus
3. To drive infections, a hijacking virus mimics a cells signaling system
4. Scripps Research Institute scientists find promising vaccine targets on hepatitis C virus
5. Harmless human virus may be able to boost the effects of chemotherapy
6. Researchers identify Achilles heel of dengue virus, target for future vaccines
7. Recapitulation of the entire hepatitis C virus life in engineered mouse cell lines
8. BGI, GMU, Mass. Eye and Ear and OUHSC announce agreement to sequence 100 human adenoviruses
9. Berkeley Lab scientists generate electricity from viruses
10. Virus barcodes offer rapid detection of mutated strains
11. Army study: DNA vaccine and duck eggs protect against hantavirus disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... Calif. , April 13, 2017 UBM,s ... York will feature emerging and evolving technology ... Both Innovation Summits will run alongside the expo portion ... speaker sessions, panels and demonstrations focused on trending topics ... largest advanced design and manufacturing event will take place ...
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
Breaking Biology News(10 mins):
(Date:8/16/2017)... ... August 16, 2017 , ... Recent studies ... type. Many treatments for specific cancers, such as breast, prostate, or lung, target ... androgen deprivation therapy for advanced prostate cancer. , This therapy limits the ...
(Date:8/16/2017)... -- This year,s edition of the Inc. 5000 features a now-familiar name: BioPoint ... made the list for the third year in a row. Now in ... based on a set of quantitative metrics. In addition, BioPoint was also ... the Bay State . ... Inc. 5000 ...
(Date:8/15/2017)... CA (PRWEB) , ... August 15, 2017 , ... ... pioneering graphene biosensors that accelerate pharmaceutical and biotherapeutics development, announces the launch of ... number of steps needed to gain kinetic binding data for a wide range ...
(Date:8/15/2017)... ... 15, 2017 , ... The Conference Forum and The Trout ... a series of upcoming panels and events. The partnership culminates with the 4th ... in New York City. , “With our experience in producing the Immuno-Oncology 360° NYC ...
Breaking Biology Technology: